AIP
CGEM icon

Ameritas Investment Partners’s Cullinan Oncology CGEM Stock Holding History

Ameritas Investment Partners’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
5,490
+1,185
+28% +$17.6K ﹤0.01% 1847
2026
Q1 		$61.2K Hold
4,305
– – ﹤0.01% 1974
2025
Q4 		$44.6K Sell
4,305
-935
-18% -$8.43K ﹤0.01% 2208
2025
Q3 		$31.1K Hold
5,240
– – ﹤0.01% 2462
2025
Q2 		$39.5K Hold
5,240
– – ﹤0.01% 2338
2025
Q1 		$39.7K Hold
5,240
– – ﹤0.01% 2242
2024
Q4 		$63.8K Hold
5,240
– – ﹤0.01% 2039
2024
Q3 		$87.7K Buy
5,240
+1,453
+38% +$25.8K ﹤0.01% 1876
2024
Q2 		$66K Buy
3,787
+1,188
+46% +$25.3K ﹤0.01% 1982
2024
Q1 		$44.3K Buy
2,599
+615
+31% +$9.5K ﹤0.01% 2221
2023
Q4 		$20.2K Hold
1,984
– – ﹤0.01% 2579
2023
Q3 		$18K Hold
1,984
– – ﹤0.01% 2594
2023
Q2 		$21.3K Hold
1,984
– – ﹤0.01% 2530
2023
Q1 		$20.3K Hold
1,984
– – ﹤0.01% 2461
2022
Q4 		$20.8K Hold
1,984
– – ﹤0.01% 2548
2022
Q3 		$25K Hold
1,984
– – ﹤0.01% 2403
2022
Q2 		$25K Hold
1,984
– – ﹤0.01% 2430
2022
Q1 		$21K Hold
1,984
– – ﹤0.01% 2535
2021
Q4 		$31K Hold
1,984
– – ﹤0.01% 2417
2021
Q3 		$45K Buy
1,984
+916
+86% +$24.5K ﹤0.01% 2231
2021
Q2 		$28K Hold
1,068
– – ﹤0.01% 2542
2021
Q1 		$45K Buy
+1,068
New +$43.4K ﹤0.01% 2139

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Ameritas Investment Partners's CGEM Position: Q2 2026 in Review

Ameritas Investment Partners increased its Cullinan Oncology (CGEM) stake by 28% in Q2 2026, buying an estimated $17.6K and bringing the position to 5,490 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Ameritas Investment Partners first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Ameritas Investment Partners held 5,490 shares of Cullinan Oncology worth $100K as of Q2 2026.
  • Ameritas Investment Partners bought 1,185 Cullinan Oncology shares in Q2 2026, an estimated $17.6K.
  • Cullinan Oncology made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1847 holding.
  • Ameritas Investment Partners first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.